マルチモーダルイメージングの市場規模、シェア、成長分析、技術別、用途別、地域別 - 産業予測、2024年～2031年

マルチモーダルイメージングの世界市場規模は、2022年に約39億米ドルと評価され、予測期間（2024-2031年）のCAGRは5.6%で、2023年の41億米ドルから上昇し、2031年には63億米ドルに達すると予測されています。

マルチモーダルイメージング市場は、SPECT/CT、PET/MR、PET/CTなど複数のイメージング技術の統合により、がん、眼科、神経疾患関連の診断能力が強化され、大幅な成長が見込まれています。この市場を推進している主な要因には、画像診断の急速な技術進歩、高齢化、ヘルスケアコストの上昇、慢性疾患の罹患率の上昇などがあります。2021年から2028年にかけて、技術開発の革新と近代的なヘルスケア慣行が、マルチモーダルイメージングアプリケーションのさらなるビジネスチャンスを生み出すと予想されます。この分野は、新しい造影剤、高度な検出器、コンピュータ支援ツールのイントロダクションより、進化する消費者ニーズに適応し、患者への正確な治療提供を保証しています。さらに、二重機能の化学染料を利用するハイブリッド光音響蛍光イメージングなどの高度なマルチモーダルイメージング技術の開発は、診断精度を高める可能性を示しています。ナノ粒子の成長と並んで、可変スペクトルと光安定性を特徴とするハイブリッド造影剤への需要の高まりが、市場の収益モメンタムを裏付けています。しかし、マルチモーダルイメージング機器の高コストや不十分なヘルスケアインフラなどの課題が成長を阻害する可能性があります。このようなハードルにもかかわらず、米国のマルチモーダルイメージング市場は今後数年間、持続可能なCAGRで成長すると予想され、ヘルスケア力学が進化する中で回復力のある見通しを示しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• バリューチェーン分析
• サプライチェーン分析
• 特許分析
• 貿易分析
• 技術分析
• ケーススタディ分析
• 価格分析

マルチモーダルイメージング市場：技術別

• 市場概要
• PET/CTシステム
• SPECT/CTシステム
• PET/MRシステム
• OCT/FMTシステム
• その他のマルチモーダルイメージングシステム

マルチモーダルイメージング市場：用途別

• 市場概要
• 腫瘍学
• 心臓病学
• 眼科
• 脳と神経学
• 研究
• その他の用途

マルチモーダルイメージング市場：エンドユーザー別

• 市場概要
• 病院
• 画像診断センター
• 学術研究機関
• その他のエンドユーザー

マルチモーダルイメージング市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• GE Healthcare
• Koninklijke Philips N.V.
• Canon Medical Systems Corporation
• Siemens Healthineers
• Zeiss Group
• Bruker
• Mediso Ltd.
• Neusoft Corporation
• Infraredx, Inc.（part of Nipro Corporation）
• Topcon Corporation
• Shanghai United Imaging Healthcare Co., Ltd.
• Heidelberg Engineering
• Spectrum Dynamics Medical
• Minfound Medical Systems Co., Ltd.
• Kindsway Biotech
• Sofie Biosciences, Inc.
• Fujifilm Corporation.

Global Multimodal Imaging Market size was valued at around USD 3.9 billion in 2022 and is expected to rise from USD 4.1 billion in 2023 to reach a value of USD 6.3 billion by 2031, at a CAGR of 5.6% over the forecast period (2024-2031).

The multimodal imaging market is poised for substantial growth, driven by the integration of multiple imaging technologies such as SPECT/CT, PET/MR, and PET/CT, which enhance diagnostic capabilities for conditions related to cancer, ophthalmology, and neurological disorders. Key factors propelling this market include rapid technological advancements in diagnostic imaging, an aging population, escalating healthcare costs, and the rising incidence of chronic diseases. Between 2021 and 2028, innovations in technical development and modern healthcare practices are expected to create further opportunities for multimodal imaging applications. This sector is adapting to evolving consumer needs with the introduction of new contrast agents, advanced detectors, and computer-aided tools, ensuring precise treatment delivery to patients. Additionally, the development of sophisticated multimodal imaging techniques, such as hybrid optoacoustic fluorescent imaging, which utilizes dual-function chemical dyes, showcases the potential for enhanced diagnostic precision. The increasing demand for hybrid contrast agents characterized by variable spectra and photostability, alongside the growth of nanoparticles, underscores the market's revenue momentum. However, challenges such as the high costs of multimodal imaging equipment and insufficient healthcare infrastructure may impede growth. Despite these hurdles, the U.S. multimodal imaging market is expected to grow at a sustainable compounded annual growth rate (CAGR) in the upcoming forecast years, indicating a resilient outlook amidst evolving healthcare dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Multimodal Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Multimodal Imaging Market Segmental Analysis

Global Multimodal Imaging Market is segmented by Technology, Application, End User, and region. Based on Technology, the market is segmented into PET/CT, PET/MR, SPECT/CT, OCT/FMT, and Other multimodal imaging. Based on Application, the market is segmented into Brain & Neurology, Cardiology, Oncology, Ophthalmology, Research Applications, and Other Applications. Based on End Use, the market is segmented into Hospitals, Diagnostic Imaging Centers, Research and Academic Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Multimodal Imaging Market

The global multimodal imaging market is poised for significant growth driven by the increasing prevalence of chronic conditions such as cancers, cardiovascular diseases, and neurological disorders. As healthcare providers recognize the need for accurate and comprehensive diagnostics, the demand for advanced multimodal imaging systems is soaring. This technology enables clinicians to integrate various imaging modalities, enhancing the identification and monitoring of chronic diseases. Furthermore, the rise in respiratory ailments, including lung cancer and COPD, is contributing to the urgent need for innovative diagnostic tools. Consequently, the escalating demand for efficient cancer screening and comprehensive disease management will propel the growth of the multimodal imaging market over the forecast period.

Restraints in the Global Multimodal Imaging Market

The Global Multimodal Imaging market faces significant restraints primarily due to the high costs associated with imaging tools and methods, which burden both patients and healthcare providers. Equipment prices, such as those for PET/CT scans ranging from $75,000 to $500,000 and gamma cameras costing between $400,000 and $600,000, pose affordability challenges, particularly in price-sensitive developing countries like India. Consequently, many healthcare facilities rely on refurbished equipment, hindering market growth. Additionally, ongoing annual maintenance costs-covering preventive upkeep, labor, and technician fees-further escalate expenses for end users. This financial strain diminishes the frequency of multimodal imaging utilization, especially in lower-income regions, ultimately stymying market expansion.

Market Trends of the Global Multimodal Imaging Market

The global multimodal imaging market is poised for significant growth, driven by ongoing technological advancements in diagnostic equipment. Innovations aimed at enhancing image quality while reducing diagnostic costs are revolutionizing patient care. Key developments include the emergence of portable imaging solutions, 5D ultrasound technology, and advancements in digital X-ray systems equipped with wireless DR detectors. The integration of three-dimensional (3D), four-dimensional (4D), and five-dimensional (5D) imaging capabilities allows for more precise diagnoses. Furthermore, companies are leveraging cutting-edge technologies such as cloud computing and artificial intelligence (AI) to refine their product offerings, positioning the multimodal imaging market for robust expansion in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Case Study Analysis
• Pricing Analysis

Multimodal Imaging Market, By Technology

• Market Overview
• PET/CT Systems
• SPECT/CT Systems
• PET/MR Systems
• OCT/FMT Systems
• Other Multimodal Imaging Systems

Multimodal Imaging Market, By Application

• Market Overview
• Oncology
• Cardiology
• Ophthalmology
• Brain & Neurology
• Research
• Other Applications

Multimodal Imaging Market, By End User

• Market Overview
• Hospitals
• Diagnostic Imaging Centers
• Academic & Research Institutes
• Other End Users

Multimodal Imaging Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeiss Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infraredx, Inc. (part of Nipro Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topcon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai United Imaging Healthcare Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heidelberg Engineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Dynamics Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Minfound Medical Systems Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindsway Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie Biosciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Corporation.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments